The Osteoarticular Manifestations in Patients With Gitelman Syndrome
Recruiting
Observational Study
Gitelman Syndrome
CPPD - Calcium Pyrophosphate Deposition Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients confirmed with Gitelman Syndrome
Exclusion Criteria:
* Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism
Contacts